Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors.
Journal: Hematology/oncology clinics of North America
Published: September 02, 2026
Subclonal IDH1/2 Mutations as a Targetable Vulnerability in Vascular Tumors.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
Correction: A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti-CTLA-4 Antibody) and Balstilimab (Anti-PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 22, 2026
Desmoid Tumors-Biology-Driven Management and Treatment Selection.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 13, 2026
Immunotherapy in the Treatment of Soft Tissue Sarcoma Since SARC028: An NCDB Analysis.
Journal: Journal of surgical oncology
Published: March 17, 2026
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: November 23, 2025
A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma.
Journal: Liver cancer
Published: October 07, 2025
Chondrosarcoma: Clinical behavior, molecular mechanisms, and emerging therapeutic strategies.
Journal: Critical reviews in oncology/hematology
Published: July 01, 2025
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.
Journal: Nature medicine
Published: June 27, 2025
Durable response with mutation-guided ALK inhibition in a patient with metastatic epithelioid inflammatory myofibroblastic sarcoma: A case report.
Journal: Rare tumors
Published: June 23, 2025
Last Updated: 09/26/2026